# The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

> **NCT01172132** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1011 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01172132
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-05
- **Final completion:** 2011-11
- **Target enrollment:** 1011 (ACTUAL)
- **Last updated:** 2016-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172132, "The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01172132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*